SIPA1 and breast cancer: Subsequent human studies demonstrated that SIPA1 polymorphisms are associated with metastatic cancer [7] and poor outcome in breast cancer [8], validating the utility of the highly metastatic polyoma middle-T (PyMT) transgenic mouse model to identify relevant human metastasis modifiers.